Close
ACHEMA MIDDLE EAST 2026
LogiPharma 2026

Drug Development

      OLUMIANT® (baricitinib) 2-mg Tablets gets FDA approval to treat adult patients with moderately to severely active Rheumatoid Arthritis

      FDA Approvals
      Eli Lilly and Company and Incyte Corporation announced today that the U.S. Food and Drug Administration (FDA) has approved the 2-mg dose of OLUMIANT®...

      Daiichi Sankyo Launches NaruveinⓇ Injection for Cancer Pain Treatment in Japan

      Drug Development
      Daiichi Sankyo Company, Limited announced that it has launched in Japan an injection for cancer pain treatment: NaruveinⓇ Injection 2 mg • 20 mg. Hydromorphone...

      Dupixent showed positive Phase 3 results in adolescents with inadequately controlled moderate-to-severe atopic dermatitis

      Clinical Trials
      A pivotal Phase 3 trial evaluating Dupixent® (dupilumab) to treat moderate-to-severe atopic dermatitis in adolescents (ages 12-17) met its primary and key secondary endpoints. In...

      LYRICA Oral Solution CV Phase 3 Trial in Pediatric Epilepsy Meets Primary Endpoint

      Clinical Trials
      Pfizer Inc. announced positive top-line results of a Phase 3 study examining the use of LYRICA® (pregabalin) Oral Solution CV as adjunctive therapy for...

      ICON Announces Clinical Research partnership with DuPage Medical Group

      Press Statements
      ICON plc , a global provider of drug development and commercialisation solutions and services, announced that PMG Research, Inc., part of ICON Site and...

      Regeneron and Sanofi Share First Positive Clinical Data for Cemiplimab in Advanced Non-small Cell Lung Cancer at ASCO

      Clinical Trials
      Regeneron Pharmaceuticals, Inc. and Sanofi announced that the first positive Phase 1 clinical data assessing cemiplimab as a potential treatment for advanced non-small cell...

      Lupin’s Nagpur facility US FDA inspection concluded with no observations

      FDA Approvals
      Pharma major Lupin announced the successful completion of an inspection carried out by the US FDA at its Nagpur facility. The inspection concluded without...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
      comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

      Resources

      Advertise

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.